Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1990 studies found for:    Open Studies | mri
Show Display Options
Rank Status Study
1 Recruiting Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
Conditions: Metastatic Malignant Neoplasm in the Brain;   Primary Brain Neoplasm
Interventions: Procedure: 3 Tesla Magnetic Resonance Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging;   Drug: Ferumoxytol;   Drug: Gadolinium;   Procedure: High Field Strength Magnetic Resonance Imaging;   Procedure: Susceptibility Weighted Imaging
2 Unknown  3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: 3-Tesla magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging
3 Recruiting Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Conditions: Glioma;   Pilocytic Astrocytoma;   Anaplastic Astrocytoma;   Glioblastoma;   Mixed Oligoastrocytoma;   Mixed Glioma;   Oligodendroglioma;   Optic Glioma;   Astrocytoma
Interventions: Procedure: MRI-guided laser ablation;   Drug: Doxorubicin;   Drug: Etoposide;   Device: Dynamic contrast-enhanced (DCE) MRI;   Device: Dynamic susceptibility contrast (DSC) MRI
4 Recruiting NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Prostate Carcinoma
Interventions: Procedure: Contrast-enhanced Magnetic Resonance Imaging;   Radiation: Fludeoxyglucose F-18;   Radiation: Fluorine F 18 Sodium Fluoride;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
5 Not yet recruiting Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer
Conditions: Stage IIB Esophageal Cancer;   Stage IIIA Esophageal Cancer;   Stage IIIB Esophageal Cancer;   Stage IIIC Esophageal Cancer
Interventions: Drug: Ferumoxytol;   Procedure: Magnetic Resonance Imaging;   Device: Magnetic Resonance Imaging;   Device: PET/CT
6 Recruiting Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
Conditions: Health Status Unknown;   Prostate Carcinoma
Interventions: Procedure: 3 Tesla Magnetic Resonance Imaging;   Radiation: Gadodiamide;   Procedure: Multiparametric Magnetic Resonance Imaging;   Procedure: Transrectal Biopsy;   Procedure: Ultrasound-Guided Prostate Biopsy
7 Recruiting FAST MRI Study in Breast Cancer Survivors
Condition: Breast Cancer
Intervention: Other: FAST MRI and mammography screening
8 Recruiting Safety Evaluation of Intra-Operative MRI-Based Guidance for Laser Ablation of Epidural Metastasis
Condition: Spinal Tumor
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Behavioral: Questionnaires
9 Recruiting MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Undifferentiated Carcinoma;   Recurrent Cervical Carcinoma;   Stage IB2 Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Radiation: Fludeoxyglucose F-18;   Procedure: Magnetic Resonance Spectroscopic Imaging;   Procedure: Positron Emission Tomography
10 Recruiting Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina
Condition: Vaginal Cancer
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Diffusion Weighted Magnetic Resonance Imaging (DWMR)
11 Recruiting Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
Condition: Adult Brain Glioblastoma
Interventions: Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging;   Drug: Ferumoxytol;   Drug: Gadoteridol;   Procedure: Magnetic Resonance Imaging
12 Not yet recruiting Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome
Condition: Reversible Cerebral Vasoconstriction Syndrome
Interventions: Device: MRI brain;   Device: ASL-MRI brain;   Device: MRA brain
13 Recruiting 68Ga-PSMA PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery
Conditions: Stage II Prostate Adenocarcinoma;   Stage III Prostate Adenocarcinoma
Interventions: Drug: gallium Ga 68-PSMA;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
14 Recruiting Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer
Conditions: Cardiovascular Injury;   Prostate Carcinoma
Interventions: Procedure: Magnetic Resonance Imaging;   Behavioral: Exercise Intervention;   Radiation: Gadopentetate Dimeglumine;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Spectroscopy;   Other: Laboratory Biomarker Analysis
15 Recruiting Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
Condition: Glioblastoma
Interventions: Procedure: Diffusion Weighted Imaging;   Drug: Gadolinium;   Other: Laboratory Biomarker Analysis;   Procedure: Magnetic Resonance Imaging;   Procedure: Perfusion Magnetic Resonance Imaging
16 Recruiting Extramedullary Leukemia (EML) in Newly Diagnosed Acute Myeloid Leukemia (AML) is Underreported
Condition: Leukemia
Interventions: Drug: 18F-FDG;   Procedure: Whole Body Magnetic Resonance Imaging (MRI);   Drug: Gadolinium;   Procedure: Positron Emission Tomography/ Computed Tomography (PET/CT)
17 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
18 Recruiting Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Conditions: Hepatocellular Carcinoma;   HCC
Intervention: Device: Magnetic Resonance Imaging
19 Recruiting 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Condition: Prostate Adenocarcinoma
Interventions: Radiation: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
20 Recruiting Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET
Condition: Rectal Neoplasms
Interventions: Other: Early MRI and PET/CT - 2 weeks after commencing chemo/RT;   Other: Late MRI and PET/CT 6 weeks post chemo/RT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years